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Thetoxicity, exposure, and riskfrom chlorpyrifos are brieflydiscussed injuxtapositionwith two
recent articles in EnvironmentalHealtb Perrpectivesconcerning potential exposures to children.
In studies conducted according to EPAguidelines, chlorpyrifos has been shown not to be muta-
genic, carcinogenic, or teratogenic, nordoes itadverselyaffict reproduction. Chlorpyrifos toxici-
tydoes notoccur inthe absence ofsignificant cholinesterase inhibition. Ifexposuresareless than
those that cause significant cholinesterase depression, then no signs or symptoms related to
chlorpyrifos exposure occur. Theweight ofempirical evidence indicates that theriskofadults or
children experiencing an adversehealth efFectfrom exposure tochlorpyrifos through both nondi-
etary and dietary sources is negligible. Both the research supporing the registration ofthese
products andtheirlonghistoryofwidespread usesuagestthat unless theseproducts are seriously
misused, their margins ofsafety are wide enough to protect everyone with the potential to be
exposed. A weight-of-evidence review ofthe entire scientific knowledge base relating to chlor-
pyrifos products supports these condusions. Key work biomonitoring, chlorpyrifos, dislodge-
able residues, exposure modeling, nondietary exposure, organophosphate insecticide, pesticide,
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The commentary by Davis and Ahmed (1)
and the study by Gurunathan et al. (4) raise
concerns aboutpotential nondietaryexposures
ofinfants and children to chlorpyrifos when
applied in the home. Dow AgroSciences is
committed to assessing and understanding
potential human exposures to all ofour prod-
ucts, including chlorpyrifos. Consequently,
although Gurunathan et al. (4 should be rec-
ognized for their novel effort to quantify
potential multipathway exposures to children,
several oftheir comments and condusions, as
well as statements by Davis and Ahmed (1),
require furtherconsideration.
Chlorpyrifos is an exceptionally well-
understood and widely studied molecule.
More than 250 studies have been conducted
examining the uses and impacts ofthis mol-
ecule on human health and the environ-
ment. Indeed, to our knowledge, no other
pest control product has been researched
more thoroughly. Further, the scientific
weight ofevidence strongly supports its safe-
tywhen used in the indoor environment.
Risk associated with any substance is a
function oftoxicity and exposure. Therefore,
both toxicity and exposure for any pesticide,
including chlorpyrifos, need to be deter-
mined and understood in order to make
informed decisions about its proper use. To
effectively and efficiently managehuman and
environmental health, both public policy
and regulatory decisions regarding risk from
any activity, including pesticide use, must be
based on sound science, particularly with
respect to empirical understandings oftoxici-
ty and exposure.
In this commentary, the toxicity, expo-
sure, and risk from chlorpyrifos are briefly
discussed. Additionally, the relationship
between the findings of Gurunathan et al.
(2) and current use patterns for chlorpyrifos
are discussed injuxtaposition to the miscon-
ceptions and misinterpretations by Davis
andAhmed (1). Finally, limitations ofanec-
dotal information and our company's prod-
uct stewardship initiatives to assure proper
and safe use ofchlorpyrifos are discussed.
Toxicity of Chlorpyrifos
In studies conducted according to EPA
guidelines, chlorpyrifos has been shown not
to be mutagenic (3), carcinogenic (4), or
teratogenic (5,6), nor does it adverselyaffect
reproduction (6). Chlorpyrifos toxicity does
not occur in the absence of significant
cholinesterase inhibition. If exposures are
less than those that cause significant
cholinesterase depression, then there are no
signs or symptoms related to chlorpyrifos
exposure. Numerous studies have shown
that inhibition of plasma cholinesterase
activity is the most sensitive indicator of
exposure to chlorpyrifos. However, there are
no known adverse effects associatedwith the
inhibition of plasma cholinesterase activity
per se (7). The existing data provide con-
vincing evidence that plasma cholinesterase
activity is depressed by much lower doses of
chlorpyrifos than those necessary to cause
signs and symptoms. Moreover, these data
show chlorpyrifos toxicity will not occur in
the absence ofsignificant inhibition ofplas-
ma cholinesterase activity.
Exposure to Chlorpyrifos
The toxicological effects of chlorpyrifos
have been extensively studied. The dose
response for chlorpyrifos is well known and
can be used to state the likelihood ofincur-
ring an effect following an exposure of a
given magnitude. Therefore, accurate
empirical exposure studies are crucial to
determining risk presented by chlorpyrifos.
The weight of empirical evidence indicates
that the risk ofadults or children experienc-
ing an adverse health effect from exposure
to chlorpyrifos through both nondietary
and dietary sources is negligible (8-10).
The objective of the Gurunathan et al.
study (2), conducted at the Environmental
and Occupational Health Sciences Institute
at Rutgers University (EOHSI), was to eval-
uate potential exposures to children follow-
ing an indoor broadcast application with
chlorpyrifos. Understanding potential mul-
tipathway exposures to compounds such as
chlorpyrifos is important. Therefore, in an
attempt to describe potential dermal and
oral exposure pathways, both plastic and
plush foam-based toys, as well as horizontal
surfaces throughout two treated apartments,
were chemically desorbed with hexane to
quantify total chlorpyrifos residues postap-
plication. The studyinvestigators extrapolat-
ed human exposure estimates by linking
these independent residue measurements
with conservative assumptions describing
potential human uptake of these residues
(i.e., activitypatterns, frequencyofskin con-
tact with contaminated surfaces, hand-to-
mouth behavioral patterns, residue dislodge-
ability, and transferability from contacted
surfaces to human skin). However, because
biomonitoring was not conducted, the
assumptions cannotbesufficientlyvalidated.
The EOHSI researchers measured
chlorpyrifos residues following an indoor
broadcast treatment, a form of application
that has been outdated by newer technolo-
gies and which Dow AgroSciences has
agreed to withdraw voluntarily on a global
basis from its product label. However, Dow
AgroSciences continues to support an
indoor crack and crevice and spot treatment
registration for chlorpyrifos. In contrast to a
broadcast application, a crack and crevice
and spot application typically consists of a
directed low volume application to cracks,
crevices, baseboards, and other sites in a
structure likely to harbor the target pests.
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Because a small volume of a dilute chlor-
pyrifos mixture is applied to somewhat
remote areas within a home, neither direct
contact with the treated areas nor
volatilization with subsequent nontarget
deposition is likely. Therefore, as con-
firmed by extensive measurements from
crack and crevice studies, both dermal and
oral exposures would be negligible in con-
trast to abroadcast application (10,11).
Similar studies for broadcast use pat-
terns incorporating environmental mea-
surements and the quantification of chlor-
pyrifos' metabolite in residents' urine
demonstrate the inherent conservatism of
many of the assumptions included in the
EOHSI study (8). Biological monitoring
results indicate that estimated exposures for
children calculated by the EOHSI investi-
gators may overestimate actual exposures
following abroadcast application byat least
one order ofmagnitude.
The EOHSI study attempted to esti-
mate residues using solvent extraction tech-
niques that overestimate actual human
exposures because of the affinity of chlor-
pyrifos to bind tightly to surface matrices
(8,10,12-14). The study assumes that all
residues present on asurface can be removed
and subsequently transferred to the skin,
where they are prone to either percutaneous
absorption or ingestion. Chlorpyrifos
residues have a high affinity for binding
with surfaces following application. Only a
very small fraction ofa measured residue is
likely to be removed when children either
contact or chew on a chlorpyrifos-contain-
ing surface (carpet or toys). The assumption
that all of the material desorbed from
polyurethane toys is available for ingestion
by a small child causes an overestimation of
actual exposures. Also, solvent-extracted sur-
faces and toys dearly overestimate an occu-
pant's potential exposure to residues.
Comprehensive exposure studies show that
less than 1% ofchlorpyrifos residues typical-
ly present on a household surface may be
transferred to the skin upon contact with the
chlorpyrifos-containing surface (8,10,13) (in
contrast to the 100% transfer factor assumed
by the EOHSI investigators). In addition,
biomonitoring of volunteers performing
child-like activities following a broadcast
application demonstrate that potential expo-
sures were approximately 10 times below
those presented in the EOHSI study (8). In
this case, exposures were well below the
acute NOEL (no observed effect level) of
500 pglkg/dayassociatedwith redblood cell
cholinesterase depression and therefore
would not result in exposures sufficient to
cause adverse health effects.
Residues sorbed into and on polyure-
thane toys or other sorbtive surfaces do not
accurately reflect potential exposures.
Substrates such as polyurethane are com-
monly used for the collection of airborne
residues ofpesticides and recommended by
the EPA's Subdivision U guidelines due to a
pesticide's affinity to bind tightly with the
material. As in the casewith routine airsam-
pling using this matrix, a solvent is used to
pull or extract the trapped chemical offthis
mediaforanalysis. Incidental surface contact
by moist hands or chewing (similar to
chemical extraction with water or a saliva-
like solvent) would not efflciently remove
the bound chemical (especially chlorpyrifos)
from the polyurethane, which is evidenced
by the need to use a nonpolar solvent to
enhance desorption efficiencies when ana-
lyzing chlorpyrifos from the monitoring
medium (15). Therefore, a child's oral or
dermal exposure is not consistent with
residue levels in or on a polyurethane toy
measured by solvent extraction. This, cou-
pled with the high hand-to-mouth behavior
estimated by the researchers, significantly
impacts and likely overestimates the
absorbed doses calculated in this study.
Consequently, these results should not be
used to describe potential risks to children
living in a recently treated home from a
crack and crevice or spot treatment.
However, until these results areproperlyval-
idated with biological monitoring tech-
niques, the investigators' findings could be
used to generate hypotheses for future
research.
Studies using crack and crevice treat-
ments show that potential exposures to
chlorpyrifos arewell within accepted health
guidelines. A comprehensive residential
exposure study to characterize potential
total exposures to children and adults over
a prolonged period following crack and
crevice applications was recendy completed
(15). Environmental and biological moni-
toring measurements were conducted to
quantify the residents' absorbed doses of
chlorpyrifos and, more importantly, to
describe precisely the relationship between
residue measurements made in the home
environment and actual bioavailability.
Both measured adult and extrapolated
child absorbed doses were well below those
estimates presented in the EOHSI study
and the relevant NOEL associated with
chlorpyrifos.
The use of both hard and soft toy
dosimeters in the recent study demonstrat-
ed negligible residue deposition on surfaces
likely to be contacted by children (15).
Although minimal residues were detected
on cotton dosimeters (used as surrogate
dosimeters to simulate nontarget deposi-
tion on household surfaces and soft toys)
over the 10-day period after application,
side-by-side dislodgeable residue measure-
ments performed on carpeted surfaces and
plastic toys adjacent to the cotton dosime-
ters showed that none of the chlorpyrifos
was dislodged upon contact with these sur-
faces. In addition, chlorpyrifos loading on
the passive cotton dosimeters was at least
400 times less than the surface loadingdoc-
umented in the EOHSI study for plush
toys.
Therefore, in contrast to the EOHSI
study in which surface residues were esti-
mated to contribute to 99% of a child's
overall exposure, dermal exposure and/or
ingestion of dislodged chlorpyrifos follow-
ing a crack and crevice application would
not likely contribute to one's overall expo-
sure (15). During a crackand crevice appli-
cation or spot application, a coarse pin
spray is typically directed into confined
spaces that may harbor crawling pests.
Because of the nature of the application,
the lowvolume applied, and the concentra-
tion of material used (0.25%-0.5%),
potential exposures are considerably less
than those following a broadcast applica-
tion. Several studies have been conducted
to evaluate exposures to residential occu-
pants following crack and crevice applica-
tions (11,16). Based on the results ofthese
studies, even assuming that a resident was
potentially exposed to the maximum con-
centration for a period of24 hr, exposures
would be approximately 73 and 365 times
below the acute NOEL associated with
depression of human plasma or red blood
cell cholinesterase, respectively. In light of
the large margins ofsafetywhen estimating
exposures to residents following typical
pesticide applications, it is extremely
unlikely that, even in the case of a misap-
plication, exposures would be sufficient to
cause asymptomatichealth effect.
Moreover, as demonstrated in the more
recent study (15), there was no discernible
biological exposure to residents attributed
to the crack and crevice treatments.
Because ofthe lack ofdislodgeable residues
on surfaces within the home following a
crack and crevice application, exposures via
either the dermal or oral route would not




Davis and Ahmed (1) discuss condusions
from a 1997 EPA memorandum concern-
ing chlorpyrifos poisoning data reported
from legal claims andsurveillance data pro-
vided by the American Association of
Poison Control Centers and the California
Pesticide Illness Surveillance Program (17).
The 1997 EPAmemorandum, which based
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its conclusions as to cause and effect on
anecdotal, inquiry-based information, is
inappropriate, particularlywhen considered
in conjunction with the abundance oftoxi-
cological data and risk assessments available
for chlorpyrifos. Further, the conclusions
and recommendations of the memoran-
dum are not even supported by the assem-
blage of anecdotal information contained
within the memorandum itself.
In response to the EPA memorandum,
DowAgroSciences, in cooperation with the
EPA, formed an eight-member multidispli-
nary panel of independent scientists from
government and academia charged with
reviewing the scientific literature on human
health effects potentially associated with
exposure to chlorpyrifos (18). The panel
was asked to 1) evaluate human experience
data available and address the adequacy of
the current database; 2) develop a list of
recommendations for potential epidemiol-
ogy studies, including suitable end points
and populations and pros and cons ofeach
approach; and 3) write a report to summa-
rize its recommendations.
The majority opinion ofthe panel (five
ofeight members) was that no further epi-
demiology studies were recommended for
populations exposed to chlorpyrifos with
respect to potential adverse effects. The
majority concluded,
Chlorpyrifos is a widely used and widely stud-
ied compound. The available scientific evidence
provides no basis for concern that it causes
human health adverse effects other than its
known cholinergic effects associated with acute
poisoning.
In reaching its conclusions, the panel
examined available scientific evidence on a
variety of neurological, behavioral, and
immunological disorders; multiple com-
plaints; and birth defects. The panel was
not persuaded after extensive review that
exposure to chlorpyrifos-containing prod-
ucts has been shown to be a cause of any
conditions described in the complaints
contained in poison control center databas-
es and cited in the EPA memo.
Davis andAhmed (1) note that prenatal
exposure to chlorpyrifos has been identified
as a possible explanation for birth defects in
children, citing Sherman (19). Articles by
Sherman have alleged that chlorpyrifos does
cause birth defects. These papers are case
reports of the same four children, with
medical details drawn from the author's
work as a consultant in litigation (19,20).
There is no consistency of symptoms
among the children, and three of the four
have been diagnosed with disorders totally
unrelated to chiorpyrifos. For two of the
four (a pair of siblings), a lawsuit has been
voluntarily dropped due to lack ofscientific
support for the claim. With a third child,
the author has stated under oath that the
mother's exposures to chlorpyrifos hap-
pened too late in the child's development to
be toxicologicallysignificant.
Sherman's work does not adhere to
general scientific standards used in medical
and clinical practice (21). Indeed, in a
recent court ruling of the U.S. District
Court for the Eastern District ofArkansas,
Western Division (21), Judge G. Thomas
Eisele stated,
I have come to the tentative conclusion that Dr.
Sherman's analysis and causation opinions are
not derived from anyaccepted scientific method-
ology (i.e., are notgrounded in the methods and
procedures ofscience) [and] are not scientifically
valid .... My tentative view is that Dr.
Sherman's case studies do nothing more scientif-
ically than to suggest acausal relation.
Commitment to Product
Stewardship
Consistent with our company's commit-
ment to continuous label improvement and
responsible product stewardship, and in
recognition of recent advancements in flea
control technology, Dow AgroSciences vol-
untarily entered into an agreement with the
EPA in June 1997 on the following 10-
point program: 1) to undertake epidemio-
logical research and establish a blue-ribbon
panel to provide scientific direction for
study design; 2) to continue the poison con-
trol center stewardship project (University
of Minnesota); 3) to withdraw from the
indoor broadcast flea control market; 4) to
withdraw from the indoor total release fog-
ger market; 5) to withdraw from the paint
additive market; 6) to withdraw from the
direct application pet care product market
(shampoos, dips, sprays); 7) to revise
labels-that had not already been revised-
to include appropriate retreatment intervals;
8) to focus pest control operator education
and training on exposure mitigation, label
improvements, and implementation of
recent notices (96-6 and 96-7); 9) to take a
leadership position with the pest control
industry to support the EPA's development
ofa new notice to cover consumer "right to
know" and indoor product "best manage-
ment practice" label revisions (e.g., "do not
apply to furniture, toys, etc,..."); and 10) to
expedite implementation ofa notice on ter-
miticide labeling and pet care product label-
ing revision (22).
Dow AgroSciences has taken a leader-
ship role in a number of areas that enable
accurate evaluation and responsible use of
pesticides in the urban environment.
Examples of this leadership include our
recent role in finalzing a notice concerning
termiticide labeling, our development of a
scientific methodology for estimating
potential aggregate exposure to pesticides
in the urban environment, and the genera-
tion of an unequaled portfolio of training
materials that we have disseminated widely
to industry professionals.
Conclusions
Dow AgroSciences recognizes that chlor-
pyrifos-containing products are used in and
around 20 million American homes each
year to protect families, their children, and
pets from disruptive and potentially health-
threatening insect pests. Both in providing
these products and in its ongoing efforts in
support of product stewardship, Dow
AgroSciences has consistently sought to
maintain the highest standards of ethics
and environmental responsibility.
Extensive research and more than 30
years of use have shown that chlorpyrifos-
containing products can be used safely by
home owners, gardeners, pest control
applicators, and others. Both the research
supporting the registrations of these prod-
ucts and their long history of widespread
use suggest that unless these products are
seriously misused, their margiips of safety
are wide enough to protect everyone with
the potential to be exposed. A weight-of-
evidence review of the entire scientific
knowledge base relating to chlorpyrifos
products supports these conclusions.
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